Results 171 to 180 of about 28,384 (222)

Outcomes With the WATCHMAN FLX in Everyday Clinical Practice From the NCDR Left Atrial Appendage Occlusion Registry

Circulation. Cardiovascular Interventions
BACKGROUND: PINNACLE FLX (Protection Against Embolism for Nonvalvular AF Patients: Investigational Device Evaluation of the WATCHMAN FLX LAA Closure Technology) demonstrated improved outcomes and low incidence of adverse events with the WATCHMAN FLX ...
Samir R. Kapadia, Robert W. Yeh, Matthew J. Price, J. Piccini, Devi G. Nair, A. Bansal, Jonathan C. Hsu, J. Freeman, T. Christen, D. Allocco, Douglas N Gibson   +10 more
semanticscholar   +1 more source

Low-Dose Direct Oral Anticoagulation vs Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion: The ADALA Randomized Clinical Trial.

JAMA cardiology
Importance Optimal antithrombotic therapy after percutaneous left atrial appendage occlusion (LAAO) is not well established as no randomized evaluation has been performed to date.
X. Freixa, Ignacio Cruz-González, P. Cepas-Guillen, Xavier Millan, Pablo Antúnez-Muiños, E. Flores-Umanzor, L. Asmarats, A. Regueiro, S. López-Tejero, Chi Hion Pedro Li, L. Sanchís, J. Rodés‐Cabau, D. Arzamendi   +12 more
semanticscholar   +1 more source

Clinical Implications of CT-detected Hypoattenuation Thickening on Left Atrial Appendage Occlusion Devices.

Radiology, 2023
Background At follow-up CT after left atrial appendage occlusion (LAAO), hypoattenuation thickening (HAT) on the atrial aspect of the device is a common finding but the clinical implications require further study. Purpose To assess the association of HAT
X. Iriart, G. Blanc, X. Bouteiller, B. Legghe, Benjamin Bouyer, Soumaya Sridi-Cheniti, Aurélien Bustin, C. Vasile, J. Thambo, M. Elbaz, H. Cochet   +10 more
semanticscholar   +1 more source

Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation.

JAMA Neurology
Importance Patients with atrial fibrillation (AF) who have ischemic stroke despite taking oral anticoagulation therapy (OAT) have a very high risk of recurrence.
M. Maarse, D. Seiffge, D. Werring, L. Boersma, E. Aarnink, N. Fierro, P. Mazzone, A. Beneduce, C. Tondo, A. Gasperetti, R. Pracoń, Marcin Demkow, K. Zieliński, O. de Backer, K. Korsholm, J. Nielsen-Kudsk, R. Estévez-Loureiro, B. Caneiro-Queija, T. Benito-González, Armando Pérez de Prado, L. Nombela‐Franco, P. Salinas, D. Holmes, A. H. Almakadma, Sergio Berti, M. Romeo, Xavier Millán Álvarez, D. Arzamendi, V. Alla, Himanshu Agarwal, Ingo Eitel, Christina Paitazoglou, X. Freixa, P. Cepas-Guillen, Rashaad Chothia, Solomon O. Badejoko, M. Bergmann, Daniel B. Spoon, James T. Maddux, M. El‐Chami, Pradhum Ram, L. Branca, M. Adamo, H. Suradi, Vincent F van Dijk, Benno J W M Rensing, Annaelle Zietz, Maurizio Paciaroni, V. Caso, Masatoshi Koga, Kazunori Toyoda, B. Kallmünzer, M. Cappellari, Duncan Wilson, S. Engelter, M. Swaans   +55 more
semanticscholar   +1 more source

Impact of intracardiac echocardiography versus transesophageal echocardiography guidance on left atrial appendage occlusion procedures: A meta‐analysis

Cardiovascular Electrophysiology, 2023
Intracardiac echocardiography (ICE) is increasingly used during left atrial appendage occlusion (LAAO) as an alternative to transesophageal echocardiography (TEE).
J. C. Diaz, Oriana Bastidas, M. Duque, J. Marín, J. Aristizábal, Cesar Niño, Carolina Hoyos, Carlos D. Matos, Mohamed Gabr, Nathaniel Steiger, S. Kapur, William H. Sauer, Jorge E. Romero   +12 more
semanticscholar   +1 more source

Hemodynamic effects of left atrial appendage occlusion

Journal of Interventional Cardiac Electrophysiology, 2021
Percutaneous left atrial appendage occlusion (LAAO) devices have emerged as alternatives to anticoagulation for embolic stroke prevention in patients with non-valvular atrial fibrillation (NVAF). The left atrial appendage is known to produce vasoactive neuroendocrine hormones involved in cardiovascular homeostasis.
Esseim Sharma, Eirini Apostolidou, Wasiq Sheikh, Anshul Parulkar, M. Bilal Ahmed, Fabio V. Lima, Brian D. McCauley, Kevin Kennedy, Antony F. Chu   +8 more
openaire   +2 more sources

Left Atrial Appendage Occlusion in Patients With Thrombus in Left Atrial Appendage

Journal of Invasive Cardiology, 2020
Atrial appendage (LAA) occlusion is a therapeutic option for thromboembolic prevention in atrial fibrillation (AF) patients who have contraindications to oral anticoagulation (OAC) or high risk of bleeding. Traditionally, thrombus in the LAA has been considered a contraindication for LAA occlusion.
Levent Sahiner, Cem Coteli, Ergun Kaya, Ahmet Ates, Gul Kilic, Hikmet Yorgun, Kudret Aytemir   +6 more
openaire   +2 more sources

Surgical ablation, left atrial appendage occlusion or both? Nationwide registry analysis of cardiac surgery patients with underlying atrial fibrillation.

European Journal of Cardio-Thoracic Surgery
OBJECTIVES The aim of this study was to evaluate in-hospital outcomes and long-term survival of patients undergoing cardiac surgery with preoperative atrial fibrillation.
Michał Pasierski, Jakub Batko, Łukasz Kuźma, W. Wańha, Marek Jasiński, K. Widenka, Marek Deja, Krzysztof Bartuś, T. Hirnle, Wojciech Wojakowski, R. Lorusso, Z. Tobota, B. Maruszewski, P. Suwalski, M. Kowalewski   +14 more
semanticscholar   +1 more source

Stroke Prevention With Prophylactic Left Atrial Appendage Occlusion in Cardiac Surgery Patients Without Atrial Fibrillation: A Meta-Analysis of Randomized and Propensity-Score Studies

Circulation. Cardiovascular Interventions
BACKGROUND: The role of left atrial appendage occlusion (LAAO) in patients without previous atrial fibrillation (AF) is not established. This meta-analysis was conducted on patients with normal sinus rhythm who underwent cardiac surgery, with and without
M. Baudo, Serge Sicouri, Yoshiyuki Yamashita, Mikiko Senzai, Patrick M. McCarthy, Marc W. Gerdisch, R. Whitlock, B. Ramlawi   +7 more
semanticscholar   +1 more source

Single antiplatelet therapy following Amplatzer left atrial appendage occlusion.

EuroIntervention
BACKGROUND The optimal antithrombotic therapy following left atrial appendage occlusion (LAAO) remains debated. Ideally, this therapy should effectively prevent device-related thrombosis (DRT) while minimising the associated bleeding risk.
A. Kramer, K. Korsholm, J. Nielsen-Kudsk
semanticscholar   +1 more source